Corrigendum: Case Report: Hodgkin Lymphoma and Refractory Systemic Lupus Erythematosus Unveil Activated Phosphoinositide 3-Kinase-δ Syndrome 2 in an Adult Patient

Frontiers in Pediatrics

Silvia Di Cesare¹  Maria Chiriaco¹  Caterina Cancrini¹  Gigliola Di Matteo²  Beatrice Rivalta²  Cristina Cifaldi²  Vittorio Stefoni³  Lucia Leonardi⁴  Francesca Conti⁵  Andrea Pession⁵  Gioacchino Schifino⁶  Rita Mulè⁷  Marco Fusconi⁷  Fabiana Sbrega⁸  Arianna Catelli⁹  Simona Ferrari^1,10 

[1] Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy;Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy;Academic Department of Pediatrics, Immune and Infectious Diseases Division, Research Unit of Primary Immunodeficiencies, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy;Institute of Hematology “L. e A. Seràgnoli”, University of Bologna, Bologna, Italy;Maternal, Infantile and Urological Sciences Department, Sapienza University of Rome, Rome, Italy;Pediatric Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy;Respiratory and Critical Care Unit - IRCCS Azienda Ospedaliero Universitaria di Bologna, Bologna, Italy;Department of Specialistic, Diagnostic and Experimental Medicine (DIMES), Alma Mater University, Bologna, Italy;Rheumatology Unit, Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy;Scuola di Specializzazione di Patologia Clinica e Biochimica Clinica, Università Alma Mater Studiorum, Bologna, Italy;Specialty School of Paediatrics - Alma Mater Studiorum, University of Bologna, Bologna, Italy;U.O. Genetica Medica, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy;

关键词: lymphoma;    refractory SLE;    immunodeficiency;    PIK3R1;    PI3K signaling;    APDS2;    IFN-signature;   

DOI  :  10.3389/fped.2021.757229

来源: Frontiers

【 授权许可】

CC BY